Lung Cancer Guidelines (Cancer Immunotherapy Guidelines-LC)
The Cancer Immunotherapy Guidelines-LC Task Force is currently developing a consensus statement specific to lung cancer.
Lung Cancer Steering Committee & Task Force Members
Cancer Immunotherapy Guidlines-LC Chair
Roy Herbst, MD, PhD - Yale Cancer Center
Steering Committee
- Julie Brahmer, MD - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Ramaswamy Govindan, MD - Washington University School of Medicine
- Naiyer Rizvi, MD - Columbia University Medical Center
Task Force
- Robert A. Anders, MD, PhD - Johns Hopkins University School of Medicine
- Scott J. Antonia, MD, PhD - Moffitt Cancer Center
- Sarah Bonerigo, PA - Johns Hopkins University School of Medicine
- Marianne Davies, NP - Yale Cancer Center
- Steven M. Dubinett, MD - David Geffen School of Medicine at UCLA
- Andrea Ferris - LUNGevity
- Leena Gandhi, MD, PhD - Dana-Farber Cancer Institute
- Edward Garon, MD - David Geffen School of Medicine at UCLA
- Matthew D. Hellmann, MD - Memorial Sloan Kettering Cancer Center
- Fred R. Hirsch, MD, PhD - University of Colorado School of Medicine
- Shakuntala Malik, MD - National Cancer Institute, National Institutes of Health
- Joel Neal, MD, PhD - Stanford School of Medicine
- Vassiliki Papadimitrakopoulou, MD - The University of Texas MD Anderson Cancer Center
- David L Rimm, MD, PhD - Yale University School of Medicine
- Lawrence H. Schwartz MD - Columbia University College of Physicians and Surgeons
- Boris Sepesi, MD, FACS - The University of Texas MD Anderson Cancer Center
- Beow Yong Yeap, ScD - Massachusetts General Hospital, Harvard Medical School
